on 18 May 2021
Last Applicant/ Owned by
3070 Kent Avenue
West Lafayette
IN
47906
Serial Number
88570495 filed on 07th Aug 2019
Registration Number
6356728 registered on 18th May 2021
Correspondent Address
Jill J. Chalmers
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Consulting services in the field of regulatory compliance in the pharmaceutical, medical and healthcare industries; regulatory services for others, namely, tracking and monitoring regulatory requirements in the field of the pharmaceutical, medical, and healthcare industries for regulatory compliance purposes Market assessment services; consulting services, namely, providing market research and bu Read More
Consulting services in the field of regulatory compliance in the pharmaceutical, medical and healthcare industries; regulatory services for others, namely, tracking and monitoring regulatory requirements in the field of the pharmaceutical, medical, and healthcare industries for regulatory compliance purposes
28th Oct 2019
28th Oct 2019
Market assessment services; consulting services, namely, providing market research and business analysis services in the pharmaceutical, medical and healthcare fields; business consulting and planning services in the field of pharmaceuticals, medicine and healthcare; business consulting and planning services in the field of the commercialization of pharmaceuticals, medicines and healthcare products; business consulting services relating to product distribution, operations management services, logistics, reverse logistics, supply chain, and production systems and distribution solutions; consulting in the fields of sales methods, sales management, and sales improvement; business consultation; business administration consultation services; business operation consultation services; business consulting services in the field of pharmaceutical manufacturing, pharmaceutical packaging, and distribution; business consulting in the pharmaceutical products, medical and healthcare industries; business consulting, business management, business advisory services; marketing consulting services in the field of pharmaceuticals, medicine and healthcare; business marketing consulting services; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; branding and marketing services for others in the field of pharmaceutical, medical, and healthcare industries; regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; advertising of custom services for pharmaceutical formulation design, design of processes to transform inorganic and organic substances, scale-up of pharmaceutical manufacturing processes, pharmaceutical technology transfer, manufacture of pharmaceuticals, and chemical and physical evaluation of pharmaceuticals for others; distributorship services of pharmaceutical and medical products for others; commercialization of pharmaceuticals and medical products for others
28th Oct 2019
28th Oct 2019
No 88570495
No Service Mark
No 1087939.4
No
No
No
No
No
No
No
No
02.11.01 -
Hearts
10.09.01 -
Medicines and nonmedical products in tablet, capsule or powder form; suppositories
24.15.04 -
Arrowheads
24.15.10 -
More than one arrow
Status Date | Action Taken |
---|---|
18th May 2021 | REGISTERED-PRINCIPAL REGISTER |
16th Apr 2021 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
15th Apr 2021 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
02th Apr 2021 | STATEMENT OF USE PROCESSING COMPLETE |
01st Apr 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
17th Mar 2021 | TEAS STATEMENT OF USE RECEIVED |
17th Mar 2021 | USE AMENDMENT FILED |
22nd Sep 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
28th Jul 2020 | PUBLISHED FOR OPPOSITION |
28th Jul 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |